ArticlePloS one2025
Towards resilience: Transcriptional insights on flavonoid biosynthesis during peanut seed maturation phases.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flavonoids are secondary metabolites widely studied as a metabolic protector against several stressors in plants, yet they are understudied in the events of peanut seed development. Substantial advances in the understanding of peanut seed maturation have been made in recent years, however, the role of flavonoids in this process is unclear. Here, the fundamental question asked was: are flavonoids involved in peanut seed maturation phases? This study investigates whether the main transcripts associated with the flavonoid pathway, such as anthocyanins, are biologically linked to the physiological quality components of peanut seeds during development. For this purpose, peanut seeds classified into five stages (R5, R6, R7, R8 and R9) were used for the evaluation of quality attributes, such as desiccation tolerance, vigor and longevity parameters, and for RNA sequencing (RNA-seq). Interestingly, anthocyanins accumulated more in the beginning of the seed filling phase, coinciding with the expression upregulation in RNA-seq and quantitative PCR of key genes in its pathway, such as AhCHS (0FI6RG), AhCHI (VJQ7J1), AhFLS (4Y1607), AhLDOX (AQ6B1J) and AhANR (IK60LM). Additionally, we found that AhMYB12 (PR7AYB) and AhMYB308 (TG6F30) exhibited increased expression at the early stages (R5 and R6) and decreased at the later ones (R7, R8 and R9). The AhCHS expression acts in synergy with well-known seed maturation regulators, such as the ABA response (e.g., ABI5 and ABI3). The involvement of flavonoid biosynthesis in peanut seed development is suggested here as a contributor to its resilience during the acquisition of physiological quality attributes, highlighting the molecular aspects associated with survival in the dry state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.